Purpose The aim of this study was to explore the relationship between non-alcoholic fatty
liver disease (NAFLD) and the two blood inflammatory markers including the systemic …

Inflammatory changes in the liver represent a key feature of non-alcoholic steatohepatitis
(NASH), the progressive form of non-alcoholic fatty liver disease (NAFLD). Innate immune …

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is an increasingly
common complication of obesity, affecting over a quarter of the global adult population. A …

Background Alcohol and obesity synergise to increase the risk of liver-related mortality. We
examined the influence of adiposity on clinical outcomes in alcoholic hepatitis (AH) and the …

Disorders such as pancreatic or hepatic fibrosis are a cruel reminder that disruption of the
delicate physiological balance could result in severe pathological consequences. Fibrosis is …

Liver pericytes, commonly named hepatic stellate cells (HSCs), reside in the space between
liver sinusoidal endothelial cells (LSECs) and hepatocytes. They display important roles in …

The liver is a vital metabolic and detoxifying organ and suffers diverse endogenous or
exogenous damage. Hepatocyte mitochondria experience various structural and functional …

The prevalence of nonalcoholic fatty liver disease (NAFLD) and the more severe and
inflammatory type, nonalcoholic steatohepatitis (NASH), is increasing rapidly. Especially in …

Introduction Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic
liver diseases. The development of NAFLD is closely associated with hepatic lipotoxicity …

Liver fibrosis and fibrosis-associated hepatocarcinogenesis are driven by chronic
inflammation and are leading causes of morbidity and death worldwide. SYK signaling …